Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
PUT
Glaukos
GKOS
$10.6B
| $970K | ﹤0.01% |
+29,400
| New | +$1.12M |
|
2527
Summit Therapeutics
SMMT
$11.1B
| $968K | ﹤0.01% |
77,114
+1,291
| +2% | +$16.7K |
|
2528
Badger Meter
BMI
$4.03B
| $967K | ﹤0.01% |
+19,730
| New | +$877K |
|
2529
Vanguard Morningstar Value ETF
VTV
$191B
| $966K | ﹤0.01% |
9,678
-15,917
| -62% | -$1.56M |
|
|
NP
2530
DELISTED
Neenah, Inc. Common Stock
NP
| $966K | ﹤0.01% |
+11,287
| New | +$894K |
|
|
LRFC
2531
DELISTED
Logan Ridge Finance Corp
LRFC
| $964K | ﹤0.01% |
16,843
-635
| -4% | -$41K |
|
|
SIOX
2532
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $963K | ﹤0.01% |
+17,500
| New | +$2.95M |
|
|
CACQ
2533
DELISTED
Caesars Acquisition Company
CACQ
| $963K | ﹤0.01% |
+44,900
| New | +$868K |
|
2534
Coherus Oncology
CHRS
$196M
| $962K | ﹤0.01% |
72,038
+42,693
| +145% | +$565K |
|
2535
Reaves Utility Income Fund
UTG
$3.61B
| $962K | ﹤0.01% |
30,332
+15,317
| +102% | +$532K |
|
2536
Wave Life Sciences
WVE
$1.2B
| $962K | ﹤0.01% |
44,241
-27,948
| -39% | -$562K |
|
2537
CALL
Regenxbio
RGNX
$708M
| $959K | ﹤0.01% |
+29,100
| New | +$655K |
|
|
PZN
2538
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $958K | ﹤0.01% |
87,947
-50,088
| -36% | -$512K |
|
2539
Rush Enterprises Class B
RUSHB
$6.14B
| $957K | ﹤0.01% |
49,370
+29,428
| +148% | +$498K |
|
2540
World Kinect Corp
WKC
$1.86B
| $957K | ﹤0.01% |
28,220
+21,779
| +338% | +$777K |
|
|
MRSN
2541
DELISTED
Mersana Therapeutics
MRSN
| $955K | ﹤0.01% |
2,210
-231
| -9% | -$91K |
|
|
BFYT
2542
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $953K | ﹤0.01% |
65,745
-109,253
| -62% | -$3.02M |
|
2543
CALL
Inogen
INGN
$164M
| $951K | ﹤0.01% |
+10,000
| New | +$964K |
|
2544
Valhi
VHI
$450M
| $951K | ﹤0.01% |
32,618
-13,951
| -30% | -$448K |
|
|
RYZ
2545
Ryerson Holding Corp
RYZ
$1.46B
| $949K | ﹤0.01% |
+87,436
| New | +$771K |
|
2546
Invesco DB US Dollar Index Bullish Fund
UUP
$422M
| $949K | ﹤0.01% |
39,227
-160,773
| -80% | -$3.89M |
|
|
BEL
2547
DELISTED
Belmond Ltd.
BEL
| $947K | ﹤0.01% |
69,364
-21,489
| -24% | -$276K |
|
2548
Axsome Therapeutics
AXSM
$10.9B
| $944K | ﹤0.01% |
170,058
+10,098
| +6% | +$54.2K |
|
2549
Schwab US Broad Market ETF
SCHB
$44.9B
| $942K | ﹤0.01% |
92,772
+31,044
| +50% | +$308K |
|
2550
Nice
NICE
$5.97B
| $940K | ﹤0.01% |
+11,555
| New | +$898K |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.